We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $3.18B
1-Year Est. Return 65.92%
This Fund
S&P 500
This Quarter Est. Return
+5.06%
1 Year Est. Return
+65.92%
3 Year Est. Return
+160.27%
5 Year Est. Return
+179.96%
10 Year Est. Return
AUM
$1.63B
AUM Growth
-$32.8M
Cap. Flow
-$57.7M
Cap. Flow %
-3.53%
Top 10 Hldgs %
22.94%
Holding
2,640
New
702
Increased
393
Reduced
359
Closed
1,162

Sector Composition

Rank Sector Weight
1 Financials 9.48%
2 Energy 7.39%
3 Technology 6.5%
4 Healthcare 5.93%
5 Industrials 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBIO icon
1301
Fortress Biotech
FBIO
$99M
$49K ﹤0.01%
+2,023
New +$64.7K
FLNT
1302
Fluent
FLNT
$132M
$49K ﹤0.01%
+3,822
New +$52.9K
LTRX icon
1303
Lantronix
LTRX
$272M
$49K ﹤0.01%
+12,057
New +$46.5K
MARA icon
1304
Marathon Digital Holdings
MARA
$3.56B
$49K ﹤0.01%
16,622
+12,300
+285% +$46.6K
VNRX icon
1305
VolitionRx Ltd
VNRX
$7.6M
$49K ﹤0.01%
+955
New +$39.3K
OASM
1306
DELISTED
Oasmia Pharmaceutical AB
OASM
$49K ﹤0.01%
+11,517
New +$24.1K
NDRA icon
1307
ENDRA Life Sciences
NDRA
$5.68M
0
RHE
1308
DELISTED
Regional Health Properties, Inc.
RHE
$48K ﹤0.01%
23,193
+22,069
+1,963% +$49.8K
MUX icon
1309
McEwen Inc
MUX
$1.14B
$47K ﹤0.01%
2,415
-2,158
-47% -$45.2K
NAK
1310
Northern Dynasty Minerals
NAK
$930M
$47K ﹤0.01%
83,320
+64,781
+349% +$35.1K
VYNT
1311
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$47K ﹤0.01%
+303
New +$44.8K
PLX icon
1312
Protalix BioTherapeutics
PLX
$190M
$46K ﹤0.01%
6,363
+4,094
+180% +$20.6K
OPGN
1313
DELISTED
OpGen, Inc
OPGN
$46K ﹤0.01%
6
-7
-54% -$54.2K
ARMP icon
1314
Armata Pharmaceuticals
ARMP
$177M
$45K ﹤0.01%
3,159
+1,949
+161% +$28.4K
CHCI icon
1315
Comstock Holding Companies
CHCI
$173M
$45K ﹤0.01%
18,598
+7,986
+75% +$21.7K
JMEI
1316
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$45K ﹤0.01%
2,112
-7,867
-79% -$158K
VEON icon
1317
VEON
VEON
$3.93B
$44K ﹤0.01%
+610
New +$44.2K
AIFC
1318
AI Financial Corp
AIFC
$58.9M
$44K ﹤0.01%
+9,365
New +$38.9K
CSCI
1319
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$44K ﹤0.01%
+255
New +$46.8K
RIBT
1320
DELISTED
RiceBran Technologies
RIBT
$44K ﹤0.01%
1,531
-3,919
-72% -$109K
CSLT
1321
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$42K ﹤0.01%
+15,513
New +$54.8K
ABIL
1322
DELISTED
Ability Inc
ABIL
$42K ﹤0.01%
+12,050
New +$53.6K
PANL icon
1323
Pangaea Logistics
PANL
$496M
$41K ﹤0.01%
+11,736
New +$38.6K
PIXY
1324
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
0
FRTX
1325
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$41K ﹤0.01%
96
+52
+118% +$21.9K

Similar funds

Virtu Financial's Q3 2018 Portfolio in Review

As of Q3 2018, Virtu Financial held 2,640 positions worth $1.63B, down 2% from $1.67B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Virtu Financial withdrew a net $57.7M in Q3 2018, closing 1,162 positions and reducing 359 holdings. Its most notable exit was Berkshire Hathaway Class B, an estimated $86M position sold in full.

By sector, the portfolio is most concentrated in Financials at 9.5% of assets, down from 9.9% a quarter earlier, followed by Energy and Technology.

Against the trend, Virtu Financial opened a new position in Berkshire Hathaway Class A worth $65.3M.

  • Virtu Financial's largest Q3 2018 buy was Berkshire Hathaway Class A: 204 shares worth $65.3M.
  • Virtu Financial added most to iShares Core S&P 500 ETF in Q3 2018, an estimated $41.2M increase.
  • Virtu Financial's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $42.8M.
  • Virtu Financial fully exited Berkshire Hathaway Class B in Q3 2018, selling an estimated $86M.
  • Virtu Financial's ten largest holdings make up 23% of its $1.63B portfolio in Q3 2018.
  • Virtu Financial opened 702 new positions and closed 1,162 in Q3 2018.
  • Virtu Financial's portfolio value fell 2% quarter-over-quarter to $1.63B.

Based on Virtu Financial's 13F filing for Q3 2018, filed 13 Nov 2018.